These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34376448)

  • 21. Evaluation of two SARS-CoV-2 IgG/IgM Rapid Tests in Capillary Blood Samples.
    Lee NY; Ham JY; Hwang N; Song KE
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study.
    Venekamp RP; Veldhuijzen IK; Moons KGM; van den Bijllaardt W; Pas SD; Lodder EB; Molenkamp R; Igloi Z; Wijers C; Dos Santos CO; Debast SB; Bruins MJ; Polad K; Nagel-Imming CRS; Han WGH; van de Wijgert JHHM; van den Hof S; Schuit E
    BMC Med; 2022 Feb; 20(1):97. PubMed ID: 35197052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study.
    Peghin M; Bontempo G; De Martino M; Palese A; Gerussi V; Graziano E; Fabris M; D'Aurizio F; Sbrana F; Ripoli A; Curcio F; Isola M; Tascini C
    BMC Infect Dis; 2022 Oct; 22(1):810. PubMed ID: 36316641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of SARS-CoV-2 detection methods using stool, blood, and nasopharyngeal swab samples.
    Oloo MA; Awandu SS; Onyango B; Magwanga RO; Oluoch AO; Lidechi S; Muok EM; Munga S; Estambale B
    Pan Afr Med J; 2023; 46():21. PubMed ID: 38107343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study.
    Schuit E; Venekamp RP; Veldhuijzen IK; van den Bijllaardt W; Pas SD; Stohr JJJM; Lodder EB; Hellwich M; Molenkamp R; Igloi Z; Wijers C; Vroom IH; Nagel-Imming CRS; Han WGH; Kluytmans JAJW; van den Hof S; van de Wijgert JHHM; Moons KGM
    BMC Med; 2022 Oct; 20(1):406. PubMed ID: 36280827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of Antigen-Based Rapid Diagnostic Test for Detection of SARS-CoV-2 Virus in Routine Hospital Settings.
    Thakur P; Saxena S; Manchanda V; Rana N; Goel R; Arora R
    Lab Med; 2021 Nov; 52(6):e154-e158. PubMed ID: 33928384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity of SARS-CoV-2 Antibody Detection Assays against S and N Proteins among Pre-COVID-19 Sera from Patients with Protozoan and Helminth Parasitic Infections.
    Yansouni CP; Papenburg J; Cheng MP; Corsini R; Caya C; Vasquez Camargo F; Harrison LB; Zaharatos G; Büscher P; Faye B; Ndiaye M; Matlashewski G; Ndao M
    J Clin Microbiol; 2022 Jan; 60(1):e0171721. PubMed ID: 34669455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing.
    Savage HR; Finch L; Body R; Watkins RL; ; ; Hayward G; Cook E; Cubas-Atienzar AI; Cuevas LE; MacPherson P; Adams ER
    PLoS One; 2022; 17(6):e0270715. PubMed ID: 35771760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concordance between two rapid diagnostic tests for the detection of antibodies against SARS-CoV-2.
    de la Iglesia J; Fernández-Villa T; Fegeneda-Grandes JM; Gómez-García M; Majo García R; López Sanz S; Mendez da Cuña P; Llaneza García M; Marcos Sádaba A; Fernández Vázquez JP
    Semergen; 2020 Aug; 46 Suppl 1():21-25. PubMed ID: 32675000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Abbott Panbio™ COVID-19 antigen detection rapid diagnostic test among healthcare workers in elderly care.
    Eikelenboom-Boskamp A; den Ouden M; de Groot T; Stobernack T; Wertheim H; Voss A
    PLoS One; 2023; 18(2):e0276244. PubMed ID: 36827362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2 : A Secondary Analysis From a Serial Home Self-testing Study.
    Soni A; Herbert C; Filippaios A; Broach J; Colubri A; Fahey N; Woods K; Nanavati J; Wright C; Orwig T; Gilliam K; Kheterpal V; Suvarna T; Nowak C; Schrader S; Lin H; O'Connor L; Pretz C; Ayturk D; Orvek E; Flahive J; Lazar P; Shi Q; Achenbach C; Murphy R; Robinson M; Gibson L; Stamegna P; Hafer N; Luzuriaga K; Barton B; Heetderks W; Manabe YC; McManus D
    Ann Intern Med; 2022 Dec; 175(12):1685-1692. PubMed ID: 36215709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining rapid diagnostic tests to estimate primary and post-primary dengue immune status at the point of care.
    Biggs JR; Sy AK; Ashall J; Santoso MS; Brady OJ; Reyes MAJ; Quinones MA; Jones-Warner W; Tandoc AO; Sucaldito NL; Mai HK; Lien LT; Thai HD; Nguyen HAT; Anh DD; Iwasaki C; Kitamura N; Van Loock M; Herrera-Taracena G; Menten J; Rasschaert F; Van Wesenbeeck L; Masyeni S; Haryanto S; Yohan B; Cutiongco-de la Paz E; Yoshida LM; Hue S; Rosario Z Capeding M; Padilla CD; Sasmono RT; Hafalla JCR; Hibberd ML
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010365. PubMed ID: 35507552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lesson Learned from Mass Antibody Rapid Diagnostic Used in the Early COVID-19 Pandemic in Indonesia Contributors.
    Indrati AR; Budiailmiawan L; Markus L; Johanis J; Logito V; Aryati
    Med Devices (Auckl); 2024; 17():113-122. PubMed ID: 38481825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virus variant-specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022.
    Wagenhäuser I; Knies K; Hofmann D; Rauschenberger V; Eisenmann M; Reusch J; Gabel A; Flemming S; Andres O; Petri N; Topp MS; Papsdorf M; McDonogh M; Verma-Führing R; Scherzad A; Zeller D; Böhm H; Gesierich A; Seitz AK; Kiderlen M; Gawlik M; Taurines R; Wurmb T; Ernestus RI; Forster J; Weismann D; Weißbrich B; Dölken L; Liese J; Kaderali L; Kurzai O; Vogel U; Krone M
    Clin Microbiol Infect; 2023 Feb; 29(2):225-232. PubMed ID: 36028089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.
    Guo CC; Mi JQ; Nie H
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10208-10218. PubMed ID: 33090430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of two rapid antigen tests against SARS-CoV-2 in neighborhoods of socioeconomic vulnerability from a middle-income country.
    Zeballos D; Magno L; Aranha Rossi T; Soares F; Pinto Junior JA; Ferreira O; Carvalho Dos Santos C; Reis JN; Torres TS; Veloso VG; Dourado I
    PLoS One; 2024; 19(6):e0298579. PubMed ID: 38905178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern.
    Bornemann L; Kaup O; Kleideiter J; Ruprecht B; Hoyer A; Panning M; Bornemann R; Wehmeier M
    Clin Microbiol Infect; 2023 Aug; 29(8):1085.e1-1085.e8. PubMed ID: 37182639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point-of-care detection of SARS-CoV-2 antigen among symptomatic vs. asymptomatic persons: Testing for COVID-19 vs. infectivity.
    Neukam K; Lucero A; Gutiérrez-Valencia A; Amaya L; Echegoyen N; Martelli A; Videla C; Di Lello FA; Martínez AP
    Front Public Health; 2022; 10():995249. PubMed ID: 36324442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.